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The tetraspan cell surface glycoprotein, CD9, has been impli-
cated in cellular signaling during growth and differentiation in
the hematopoietic and nervous systems. Because CD9 expres-
sion is induced early in development in sensory and sympa-
thetic neuroblasts, we investigated the role of CD9 in neurite
outgrowth. We plated dissociated cells from neonatal sympa-
thetic ganglia on immobilized anti-CD9 antibodies or antibodies
against other cell surface molecules. We show here that
B2C11, an anti-CD9 antibody that has been shown previously
to activate Schwann cells in vitro, promotes robust neurite
outgrowth from sympathetic neurons that is greater than that
on other antibody surfaces and is comparable to neurite out-
growth on a collagen substratum. In addition, B2C11 causes
dramatic morphological changes in neurons and glia from dis-
sociated ganglia, including a flattening of these cells.
Because CD9 interacts with integrins in many cell types
including Schwann cells, and specifically with the a3b1 in-
tegrin in some cells, we tested whether the effect of B2C11
on neurite outgrowth is mediated by this integrin. An anti-
a3b1 antibody, Ralph 3–1, attenuates the extent of neurite
outgrowth on B2C11 and collagen, but not on laminin. Be-
cause the a3b1 integrin has been shown to mediate neurite
outgrowth on different substrates, these results provide a
functional significance for the CD9-a3b1 interaction; down-
stream signaling may be activated by this cis interaction on
the cell surface in response to external cues that promote
neurite outgrowth.
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During the course of nervous system development, neurons ex-
tend neurites that traverse long distances to establish highly
selective connections. This process involves diffusible chemoat-
tractants and chemorepellents such as the recently described
netrins and semaphorins (Keynes and Cook, 1995) as well as ECM
and cell surface molecules (Venstrom and Reichardt, 1993;
Letourneau et al., 1994). The ECM components involved in neurite
outgrowth include collagen; laminin; fibronectin; thrombospondin
and vitronectin, which interact with heterodimeric cell surface
receptor proteins known as the integrins (Rathjen, 1991;
Reichardt and Tomaselli, 1991; Hynes and Lander, 1992; Letour-
neau et al., 1994). Other cell surface adhesion molecules involved
include the cadherins and immunoglobulin superfamily members
(Rathjen, 1991; Hynes and Lander, 1992). The cellular signaling
cascades that lie downstream of these first-order interactions and
lead to cytoskeletal rearrangements and process extension are
also being elucidated (Doherty and Walsh, 1994; Tanaka and
Sabry, 1995).
The tetraspan integral membrane proteins constitute an-
other family of cell surface molecules that is involved in inter-
cellular signaling (Wright and Tomlinson, 1994). One of these
proteins, CD9, has been recently described in the rat nervous
system (Tole and Patterson, 1993; Kaprielian et al., 1995). CD9
interacts in cis (within the membrane of the same cell) with
members of the integrin protein family in many cell types, and
many of the functions ascribed to CD9 may depend on CD9 –
integrin interactions (Higashihara et al., 1985; Slupsky et al.,
1989; Letarte et al., 1992; Rubinstein et al., 1994; Nakamura et
al., 1995; Shaw et al., 1995).
CD9 is expressed in Schwann cells during development (Kap-
rielian et al., 1995) and after injury (Banerjee and Patterson,
1995) in a pattern that mimics the myelin genes, suggesting the
possibility that CD9 may play a signaling role in vivo. Moreover,
experiments using mAbs against CD9 have implicated this protein
in Schwann cell adhesion, proliferation, and migration (Anton et
al., 1995; Hadjiargyrou and Patterson, 1995).
CD9 is also expressed by neurons (Tole and Patterson, 1993;
Kaprielian et al., 1995). Although CD9 is not detectable on
migrating neural crest cells, expression is upregulated very soon
after these cells coalesce into various tissue derivatives (E11-E12
in the rat), and CD9 is found on the surface of neuroblasts in the
SCG at E12 and in DRG at E15. This time of onset of CD9
expression is correlated with the early stages of neuronal differ-
entiation (Tole and Patterson, 1993), and prompted us to inves-
tigate the role of CD9 in neurite outgrowth. We find that one
anti-CD9 mAb specifically stimulates neurite extension and in-
duces cytoskeletal rearrangement and dramatic morphological
changes in the somas and processes of cultured sympathetic
neurons and glia. We further demonstrate that an Ab against the
a3b1 integrin attenuates the extent of neurite outgrowth induced
by the anti-CD9 mAb.
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MATERIALS AND METHODS
Antibodies. mAbs utilized in these experiments were described previ-
ously (DeFreitas et al., 1995; Hadjiargyrou et al., 1996). Briefly, mAbs
to rat surface proteins, CD9 (ROCA1, ROCA2 and B2C11), p75LNGFR
(192-IgG), Thy-1 (OX-7), a heparan sulfate proteoglycan (pg22), and
the a3b1 integrin (Ralph-1) are all mouse IgGs. They were purified
from hybridoma supernatants using the mAb Trap-G kit (Pharmacia)
and stored at 280°C in a solution containing 1 M glycine-HCl, pH 2.7,
and 60 mM Tris-HCl, pH 9 (final, pH 7.6). The Ralph-1 mAb was a
generous gift of Dr. Louis Reichardt (University of California, San
Francisco, CA), and purified IgGs and F(ab) fragments of an NCAM
mAb were a generous gift of Dr. Urs Rutishauser (Case Western
Reserve University, Cleveland, OH).
Sympathetic neuronal cultures. Superior cervical ganglia were dissected
from neonatal rats and enzymatically dissociated as described previously
(Banerjee and Patterson, 1995). Dissociated cells were plated on various
surfaces and grown in complete medium: L15-CO2 containing fresh
vitamin mix (Hawrot and Patterson, 1979), 5 mg / ml bovine insulin
(Sigma, St. Louis, MO), 100 mg /ml transferrin (Sigma), and 100 ng / ml
NGF (Boehringer– Mannheim, Indianapolis, IN).
Neurite outgrowth assays. For quantitation of neurite outgrowth, 8-well
glass slides (Roboz Surgical Instrument Co. Inc., Rockville, MD) were
Figure 1. Immonostaining of SCG cultures with various mAbs. All mAbs used here stain sympathetic neurons, and most also stain glial cells. Dissociated
SCGs were plated on collagen, cultured for 16 hr, and immunostained with pg22 (B), OX-7 (D), 192-IgG (F ), ROCA2 (H ), or B2C11 (J ). The
corresponding phase contrast micrographs are shown in A, C, E, G, and I, respectively. The arrows and arrowheads point to glial cells and demonstrate
that whereas 192-IgG, ROCA2, and B2C11 recognize Schwann cells, pg22 and OX-7 do not seem to do so. Bar, 100 mm.
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sterilized by first being immersed in 95% ethanol, followed by flaming.
Each well of the 8-well slide was coated with 5 ml of a solution of 5 cm2
of type BA85 nitrocellulose (Schleicher & Schuell, Keene, NH) dissolved
in 6 ml methanol (Lagenaur and Lemmon, 1987), and allowed to dry in
a tissue culture hood. Each purified mAb (5 mg / ml), which was diluted in
100 mM carbonate buffer, pH 9.6, and rat tail collagen (Hawrot and
Patterson, 1979), were added to the wells (50 ml total volume). The mAbs
were allowed to bind to the nitrocellulose for 2–4 hours at room tem-
perature (RT), followed by 2 washes with 13 PBS. To prevent nonspecific
cell binding, the wells were then blocked for 1 hr at 37°C with a 5% BSA
solution (in PBS), and washed twice with PBS.
Dissociated SCG cells were either directly added to each well at a
Figure 3. B2C11 and OX-7 promote neurite outgrowth. Dissociated sympathetic neurons that had been cultured for 16 hr and stained for
peripherin display robust neurite outgrowth on collagen, OX-7, and B2C11. On pg22, ROCA2, and 192-IgG, however, there is little or no neurite
outgrowth. Bar, 25 mm.
4
Figure 2. mAbs against NGFR, CD9, and Thy-1 promote neuronal
adhesion. Dissociated SCG cells that had been cultured for 16 hr were
immunostained for peripherin after careful washing. The number of
neurons, identified by peripherin immunoreactivity, which adhered on
each surface, was determined by microscopy. For each condition, four
separate wells were established, and the data shown are mean 6 SEM
from quadruplicate determinations.
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density of 5 3 103 cells/well in 50 ml L15-CO2 medium, or preincubated
with mAbs before plating. In the latter case, 5–6 3 103 cells were
incubated for 30 min in 50 ml complete medium containing 100 mg/ml of
either Ralph 3-1 anti-N-CAM IgG, anti-NCAM F(ab), or no Ab as
controls. In one experiment, cells were incubated for 1 hr in 50 ml
complete medium containing 20 mg /ml of either Ralph 3-1 or pg22 (data
not shown). Cells were then added in this medium to the wells prepared
as described above. The cultures were incubated at 37°C for 16 hr, washed
well in L15-CO2 medium by flooding the well twice with medium and
removing it, and fixed in 4% paraformaldehyde for 15 min at RT. They
were then stained with anti-peripherin or anti-S100 Abs.
Cells were viewed on an inverted Nikon fluorescence microscope
(Diaphot 300) and quantitated by scoring neuron numbers in the same
standard area (approximately 3.5 mm2) on all surfaces. The length of
neurite outgrowth was measured using a eyepiece micrometer. Adhesion
and neurite outgrowth was measured in quadruplicate wells in individual
experiments for each condition used, and the data are expressed as
mean 6 SEM of four determinations from a single experiment. Each
experiment was repeated 4–5 times, but the data were not combined
because the total number of neurons varied somewhat between experi-
ments. The percentage of neurons with neurites was consistent for the
different experiments, however, as were the fold differences between the
different conditions used.
For the blocking experiments with integrin Abs, results from six wells
from two different experiments were combined, and the results presented
are mean 6 SEM of these six determinations.
Immunocytochemistry. To test the ability of various mAbs to bind to
sympathetic neurons, dissociated SCG cells were plated on 8-well sterile
glass slides prepared as described above on rat tail collagen at a density
of 1.5 3 104/well. The cultures were grown for 16 hr, and the cells were
stained for surface antigens with purified mAbs (5 mg /ml) for 60 min at
RT. Cells were then washed with culture medium and fixed in 4%
paraformaldehyde for 15 min at RT. After fixation, cells were washed
twice with PBS and incubated for 45–60 min at RT with FITC-
conjugated, goat anti-mouse IgG secondary Ab (Hi-F, Antibodies, Inc.)
diluted 1:200 in medium. Cells were then washed three times with PBS,
and the slide was mounted in glycerol containing 8 mg/ml n-propyl gallate
(dissolved in 100 mM Tris-HCl, pH 9). Cells were viewed and photo-
graphed using an inverted Nikon fluorescence microscope (Diaphot 300).
S100 immunohistochemistry was performed as described previously
(Banerjee and Patterson, 1995), except that the secondary Ab was an
anti-rabbit Ab conjugated with FITC (Vector Laboratories, Burlingame,
CA) and the stained material was mounted in glycerol containing
n-propyl gallate, as described above.
Peripherin immunohistochemistry was performed by incubating the
fixed cultures with anti-peripherin polyclonal Ab (Chemicon Interna-
tional, Temecula, CA) diluted 1:1000 in PBS containing 2% goat serum
and 0.1% NP-40. After washes in PBS, cells were incubated with an
FITC-conjugated anti-rabbit secondary Ab (Vector Laboratories),
washed, and mounted in glycerol containing n-propyl gallate.
RESULTS
B2C11 and control Abs recognize cultured
sympathetic neurons and glia
All of the purified mAbs used in these experiments bind well to
living, dissociated cells from neonatal rat sympathetic ganglia. In
addition to the CD9-activating mAb (B2C11; Hadjiargyrou and
Patterson, 1995; Kaprielian et al., 1995), other mAbs used recog-
nize CD9 (ROCA1 and ROCA2), the low affinity NGF receptor
(192-IgG), Thy-1 (OX-7), and a heparan sulfate proteoglycan
(pg22), and were chosen because of their reported ability to
recognize sympathetic neurons (Mason and Williams, 1980; Chand-
ler et al., 1984; Matthew et al., 1985; Mahanthappa and Patterson,
1992). Also, all the antigens are cell surface molecules, and the
corresponding mAbs are of the IgG isotype. As shown in Figure 1,
pg22, OX-7, 192-IgG, and ROCA2 recognize and strongly immu-
nostain the surface of neurons, as defined by morphology shown
in the respective phase contrast micrographs. In addition, 192-IgG
and ROCA2 immunostain the surface of Schwann cells (Fig. 1,
E–H, arrows). The anti-CD9 mAb ROCA1 is an exception; it does
not label sympathetic neurons (data not shown), consistent with
the report by Kaprielian et al. (1995) that although ROCA1
immunoprecipates CD9 and recognizes CD9 on Western blots, it
does not stain the surface of living cells. B2C11 recognizes both
Schwann cells and neurons in dissociated SCG cultures (Fig. 1).
The mAb concentration used for histological staining, 5 mg /ml, is
the same as that used to coat surfaces in the experiments de-
scribed below.
Neurons adhere to immobilized B2C11
Using the experimental paradigm used to show that immobilized
B2C11 activates Schwann cells (Hadjiargyrou and Patterson,
1995), sympathetic ganglia were dissociated and plated either on
rat tail collagen type I or on various mAbs that had been immo-
bilized on a nitrocellulose surface. Cells that had been cultured
for 16 hr on the various surfaces were washed gently and fixed.
Neurons were identified by immunostaining for peripherin, a
neuron-specific intermediate filament protein (Portier et al.,
1984). The number of peripherin-immunoreactive cells that re-
main on each surface after washing was determined. As shown in
Figure 2, neurons adhere well on a variety of surfaces; numbers of
neurons on B2C11, OX-7, and 192-IgG are comparable to those
on the adhesive ECM protein, rat tail collagen type I. Adhesion is
somewhat less on immobilized pg22 and ROCA2. In two other
experiments, cells adhered well on collagen, B2C11, 192-IgG, and
OX-7, and less well on pg22 and ROCA2 (approximately three- to
fivefold more cells adhered to B2C11 than to pg22 and ROCA2),
although the total number of cells on each surface varied some-
what from experiment to experiment. In experiments where the
cultures were not washed before fixation, the numbers of cells on
all surfaces were comparable (data not shown).
Neurons extend processes on B2C11
After 16 hr in culture, sympathetic neurons display robust neurite
outgrowth on certain surfaces. Shown in Figure 3 are representa-
tive examples of neurite outgrowth on each surface tested. As
Figure 4. B2C11 and OX-7 promote neurite outgrowth. Sympathetic
neurons were identified by peripherin immunoreactivity after culturing for
16 hr. Neurons with neurite lengths greater than 100 mm were scored as
neurite-bearing cells, and the percentage of neurons that were neurite
bearing was quantitated. For each condition, four separate wells were
established, and the data shown are mean 6 SEM from these quadrupli-
cate determinations.
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would be expected, extensive neurite outgrowth is observed on rat
tail collagen, a surface well characterized as favorable to neurite
outgrowth. In contrast, neurons on pg22, 192-IgG, and ROCA2
display limited neurite outgrowth. Consistent with a previously
demonstrated role for Thy-1 in neurite outgrowth (Leifer et al.,
1984, 1991; Mahanthappa and Patterson, 1992), many neurons
put out neurites on immobilized OX-7. Extensive neurite out-
growth that is more robust than that on OX-7, and comparable to
that observed on collagen, is observed on B2C11.
To quantitate the extent of neurite outgrowth, the percentage
of neurons bearing neurites, as well as the length of neurites, was
determined on each surface. The number of neurons with pro-
cesses more than 100 mm in length were categorized as neurite-
bearing cells. The percentages of neurite-bearing cells on each
surface were consistent in four separate experiments. As shown in
Figure 4, the percentage of neurons that extend neurites on
immobilized B2C11 is similar to that on rat tail collagen type I. A
smaller percentage of neurons extend neurites on OX-7. Neurons
did not extend neurites on immobilized pg22 or ROCA2 in this
experiment, and only a small percentage of cells had neurites on
192-IgG. In three other experiments, the mean percentages of
neurite-bearing neurons were 40–62% on collagen, 41–54% on
B2C11, 0–15% on pg22, 0–10% on ROCA2, 23–32% on OX-7,
and 3–20% on 192-IgG. In experiments where the cultures were
Figure 5. Neurite length on B2C11 is equivalent to that on collagen. Neurite length was measured using an eyepiece reticule and was divided into classes,
and the number of neurons with neurite lengths in each class was plotted for each condition. Neurite length on B2C11 is almost as long as that on collagen
and much longer than that on OX-7. In this experiment, no neurites were observed from neurons on pg22 or ROCA2.
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not washed before they were fixed and immunostained, numbers
of neurons on pg22 and ROCA2 were comparable to the other
surfaces. In these cases as well, the percentage of neurons with
neurites were 7–17%, suggesting that fewer cells adhering to pg22
and ROCA2 after washing does not result in an underestimation
of the percent outgrowth on these surfaces.
The length of the neurites on each of the surfaces was also
quantitated. The representative data shown in Figure 5 were
obtained from the same experiment shown in Figures 2 and 4, and
the data were pooled from quadruplicate cultures in a single
experiment. These experiments were repeated three times, with
the same overall trends shown in Figure 5. The neurite lengths
were pooled in bins, and the number of neurons with neurite
lengths in each bin in one experiment are shown in Figure 5,
where each bin is represented as a bar. In three experiments,
38–62% of neurons on B2C11 have neurites in the smallest length
bin, and 2–15% of neurons have neurites in the longest length bin.
On rat tail collagen, the corresponding values are 23–40% (small-
est length bin) and 3–23% (longest length bin). On OX-7, the
corresponding values are 50–55% and 0–13%. These profiles
indicate that neurons on B2C11 have neurite lengths shorter than
those on collagen type I and longer than those on OX-7. In all
experiments, the majority of neurite lengths of neurons on pg22,
192-IgG, and ROCA2 were confined to the bin with shortest
length neurites (Fig. 5; data not shown).
A mAb against the a3b1 integrin attenuates neurite
outgrowth on B2C11
To determine whether the effects of B2C11 depend on a previ-
ously demonstrated association of CD9 with the a3b1 integrin, we
tested the effect of a function-blocking mAb to a3b1, Ralph 3–1
(DeFreitas et al., 1995), on the extent of sympathetic neurite
outgrowth on various surfaces. To do so, we preincubated disso-
ciated SCG cells with either Ralph 3–1 or a variety of control
mAbs, then plated them on either rat tail collagen, B2C11 or
OX-7, as described above. In addition, we also plated these cells
on 1 mg /ml laminin, which results in neurite outgrowth that is
comparable to that on B2C11 and collagen, at the concentrations
used in this study. As shown in Figure 6, Ralph 3–1 decreases the
extent of neurite outgrowth by 38% on B2C11, 45% on OX-7, and
36% on collagen type I. Ralph 3–1 does not significantly modify
the extent of neurite outgrowth on laminin, consistent with a
previous report (DeFreitas et al., 1995). F(ab) fragments of an
anti-NCAM mAb were used as one control and do not show any
effect on outgrowth on on any surface. In addition, the intact
Figure 6. Anti-a3b1 mAb attenuates neurite
outgrowth on B2C11 and OX-7. Dissociated
SCG cells were preincubated with either
Ralph 3–1 (anti-a3b1, hatched bar), anti-
NCAM F(ab) ( gray bar), or no Ab (black bar)
and plated on collagen, B2C11, OX-7, or
laminin. Percentages of peripherin-
immunoreactive cells with neurites on various
surfaces were quantitated. Data shown are
mean 6 SEM from six wells from two differ-
ent experiments.
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anti-NCAM mAb and an anti-pg22 mAb also do not show any
effect on neurite outgrowth (data not shown).
Morphology of neurons and Schwann cells is altered
on B2C11
In addition to the robust neurite outgrowth observed on B2C11,
this mAb induces dramatic morphological changes in the neurons.
Unlike the round, phase-bright morphology seen on all other
surfaces (Fig. 3), a large percentage of neurons flatten out on
B2C11, and a peripherin-positive cytoskeleton in the flattened
soma is easily seen (Fig. 7). In addition, neurites and growth cones
also assume a flattened morphology on B2C11 (Fig. 7, arrow). A
small percentage of neurons and neurites do, however, retain their
usual three-dimensional morphology. Because peripherin is an
intermediate filament, these results suggest a dramatic rearrange-
ment of the cytoskeleton induced by neurons binding B2C11.
To determine whether this altered morphological phenotype on
B2C11 is restricted to neurons, we also tested B2C11 on gangli-
onic glial cells. S-100-positive glia have the expected bipolar
morphology on collagen, as well as on 192-IgG, ROCA2, pg22,
and OX-7 (Fig. 8). In contrast, on B2C11 (Fig. 8F), Schwann cells
lose the bipolar shape and flatten out. A thinning of the cyto-
plasm, probably because of excessive spreading of the cell mem-
brane, is observed, causing gaps in the cytoplasm in some cases;
these areas are apparently devoid of cell membrane (Fig. 8F,
arrow). These results are consistent with previously observed
spreading of the S-16 Schwann cells on B2C11, observed starting
at 2 hr after plating and extending up to 72 hr (Hadjiargyrou and
Patterson, 1995).
DISCUSSION
CD9, a member of the tetraspan family of cell surface molecules,
has been implicated as a signaling molecule in various cellular
processes such as adhesion, growth, motility, and differentiation in
the hematopoietic and nervous systems (Wright and Tomlinson,
1994; Anton et al., 1995; Banerjee and Patterson, 1995; Hadjiar-
gyrou and Patterson, 1995). The ability of activating anti-CD9
mAbs to cause cellular changes was utilized to elucidate many of
these functions. Here we show that B2C11, an anti-CD9 mAb that
has previously been demonstrated to stimulate adhesion, migra-
tion, and proliferation of Schwann cells (Anton et al., 1995;
Hadjiargyrou and Patterson, 1995), induces neurite outgrowth in
sympathetic neurons and morphological changes in neurons and
glial cells from dissociated sympathetic ganglia.
Neurite outgrowth on B2C11 is comparable to that on rat tail
collagen type I and enhanced compared to other mAb surfaces
used in our assays, in both the percentage of neurons with neurites
as well as in the length of neurites (Figs. 3–5). Moreover, striking
morphological changes in neurons and glial cells are observed
only when these cells are plated on B2C11, indicating a reorga-
nization of cytoskeletal components induced by B2C11 activation
(Figs. 7, 8).
The neurite outgrowth and morphological changes are not a
general consequence of the presence of IgG molecules immobi-
lized on the culture surface because ROCA1 (data not shown),
which does not recognize the neuronal surface under these con-
ditions, or pg22, ROCA2, and 192-IgG, which do bind the neu-
rons, cause any significant changes. The observation that ROCA2
does not activate the cells, even though it recognizes CD9 with an
affinity similar to B2C11 (Hadjiargyrou and Patterson, 1995),
suggests that the effects of B2C11 are a result of an epitope-
specific perturbation of CD9. In addition to collagen type I and
B2C11, another mAb used as a control in our experiments, OX-7,
which recognizes Thy-1, also induces neurite outgrowth. This
result is consistent with previous studies showing that OX-7 en-
hances sympathetic neurite outgrowth when added in solution
(Mahanthappa and Patterson, 1992; Doherty et al., 1993). Fur-
thermore, OX-7 and a different anti-Thy-1 mAb, 2G12, enhance
neurite outgrowth from retinal ganglion cells when immobilized
on glass (Leifer et al., 1984, 1991). The spreading phenotype of
both Schwann cells and neurons observed on B2C11 is, however,
unique to this surface and is not seen on OX-7, rat tail collagen,
or on any other surface tested. Spreading of S-16 Schwann cells
has also been observed on B2C11 but not on 192-IgG (Hadjiar-
gyrou and Patterson, 1995).
CD9 perturbation with anti-CD9 mAbs has been used exten-
sively in both the hematopoietic and nervous systems to explore
possible functions of CD9. For example, anti-CD9 mAbs cause
platelet aggregation (Griffith et al., 1991 and references therein),
homotypic adhesion of pre-B cell lines (Masellis-Smith et al.,
1990), adhesion of pre-B cells to bone marrow fibroblasts
(Masellis-Smith and Shaw, 1994), neutrophil adhesion to endo-
thelium (Forsyth, 1991), increased adhesion of primary Schwann
cells, increased adhesion and proliferation of a Schwann cell line
(Hadjiargyrou and Patterson, 1995), and enhanced Schwann cell
migration (Anton et al., 1995). The ability of anti-CD9 mAbs to
activate cells may be a result of the ability of the mAb to mimic a
putative ligand for CD9. In this model, the mAb replicates the
action of a CD9 ligand. A similar mode of activation has been
Figure 7. B2C11 induces altered neuronal morphology. Two examples of
peripherin-immunoreactive cells on B2C11 are illustrated. Many of the
cell bodies flatten out, and a peripherin-positive network is evident in
somas, as well as in some neurites and growth cones (arrow). Bar, 25 mm.
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proposed for neurite outgrowth triggered by the OX-7 mAb,
where it may mimic the natural ligand for endogenous Thy-1
(Doherty et al., 1993). An alternative model in which the anti-
CD9 mAb works by causing the aggregation and/or internaliza-
tion of CD9 seems unlikely in view of the fact that in our
experiments the ROCA2 mAb, which binds CD9 very well, does
not activate the cells.
The dramatic effects of B2C11 on neurite outgrowth and cell
morphology support a previously suggested developmental role
for CD9 (Tole and Patterson, 1993). During embryogenesis, CD9
is expressed on several neuronal populations (Tole and Patterson,
1993; Kaprielian et al., 1995). In sympathetic neurons, CD9 is
expressed at E12, very soon after neural crest cells have formed
ganglia. Although sympathetic neuroblasts continue to divide at
this stage, neuronal differentiation is concurrent with mitosis
(Rohrer and Thoenen, 1987; DiCicco-Bloom et al., 1990). Thus,
CD9 expression is correlated with very early neuronal differenti-
ation (Tole and Patterson, 1993). Sensory ganglia express CD9 at
E15, which also corresponds to very early neurite outgrowth,
which is a postmitotic event in these cells. (Rohrer and Thoenen,
1987; Tole and Patterson, 1993). This correlation is particularly
striking in the ventral horn of the spinal cord, where CD9 expres-
sion parallels the transient expression of other surface proteins
involved in neurite outgrowth such as TAG-1 (Dodd et al., 1988)
and DM-GRASP/SC1 (Burns et al., 1991; Tanaka et al., 1991;
Tole and Patterson, 1993). CD9 expression in myelinating
Schwann cells during development and after injury in vivo also
suggests that immature Schwann cells do not express CD9,
whereas differentiating Schwann cells do so (Banerjee and Patter-
son, 1995; Kaprielian et al., 1995).
Our results provide further experimental evidence that CD9
may play an early role in neurite outgrowth. It is therefore
interesting that in many cell types, CD9 interacts with various
integrins, receptors that are critical for the neuronal response to
outgrowth-promoting molecules and that are associated with
downstream signaling events leading to cytoskeletal rearrange-
ments and process extension (Reichardt and Tomaselli, 1991).
Induction of platelet aggregation by an anti-CD9 mAb causes a
specific association of CD9 with the GPIIb-IIIa integrin, and this
association is necessary for cell activation (Higashihara et al.,
1985; Slupsky et al., 1989). CD9 associates with the a3, a6, and b1
integrins in Schwann (Hadjiargyrou et al., 1996) and neuroblas-
Figure 8. B2C11 induces altered glial morphology. Dissociated SCG cells that had been cultured for 16 hr were immunostained for S100, a glial cell
marker. Glia grown on collagen (A), 192-IgG (B), ROCA2 (C), pg22 (D), and OX-7 (E) have the normal bipolar morphology. On B2C11, in contrast,
glial cells flatten out, with a thinning of the cytoplasm (F ). Bar, 25 mm.
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toma cells (Schmidt et al., 1996). In pre-B and megakaryocytic cell
lines, CD9 associates with the b1 chain-containing VLA-4 and
VLA-5 integrins, which leads to cell aggregation (Letarte et al.,
1992; Rubinstein et al., 1994). The b1 chain specifically interacts
in cis with CD9 when transfected into L cells (Rubinstein et al.,
1994), and the enhanced motility of a B cell line as a result of CD9
transfection is dependent on b1 integrins (Shaw et al., 1995).
Monkey and human CD9 associate with a3b1; in Vero cells,
monkey CD9 colocalizes with the juxtacrine growth factor HB-
EGF and a3b1 at sites of cell–cell contact (Nakamura et al.,
1995). CD9 also associates with a3b1 and a6b1 in various tumor
cell lines (Berditchevski et al., 1996).
It is of interest that the b1 integrins have been implicated in
neurite outgrowth from a variety of neurons on various substrates
(for example, Cohen and Johnson, 1991; Engvall et al., 1992;
Tomaselli et al., 1993). Specifically, retinal cells and ciliary neu-
rons use a6b1 as a laminin receptor (DeCurtis et al., 1991;
Weaver et al., 1995), and a8b1 promotes neurite outgrowth of
sensory neurons on fibronectin (Muller et al., 1995) and sensory
and motor neurons on tenascin-C (Varnum-Finney et al., 1995).
In addition to interacting with CD9, the a3b1 integrin has been
implicated as a receptor for epiligrin, laminin-5, a2b1, collagen,
and fibronectin (Wayner and Carter, 1987; Elices et al., 1991;
Symington et al., 1993; Tomaselli et al., 1993; Weitzman et al.,
1993). In addition, a3b1 is the neuronal receptor mediating sym-
pathetic neurite outgrowth in response to thrombospondin, and
direct binding between a3b1 and thrombospondin has been
shown (DeFreitas et al., 1995). a3b1 also mediates sensory neu-
rite outgrowth on laminin-1 and laminin-2 (Tomaselli et al., 1993),
neurite outgrowth from ciliary ganglion neurons on laminin
(Weaver et al., 1995), and neurite outgrowth from PC12 cells on
laminin-1, but only indirectly (Tomaselli et al., 1990). Because
most of these interactions were defined by functional perturbation
by anti-integrin antibodies, it is possible that in some cases a3b1
is an accessory to ECM ligand interactions with their receptors,
rather than itself acting as an ECM receptor. Our results suggest
that the a3b1 integrin may be involved in the interaction of CD9
with a putative ECM ligand (mimicked here by B2C11).
The neurite outgrowth-promoting activity of both B2C11 and
OX-7 were significantly attenuated by the presence of an anti-
a3b1 integrin mAb, suggesting an involvement of this integrin in
neurite outgrowth mediated by CD9 and Thy-1. In this context, it
is important to note that in addition to expressing CD9, neonatal
sympathetic neurons also express a3b1, both in vitro and in vivo
(DeFreitas et al., 1995). Because the inhibition caused by the
anti-a3b1 mAb is not complete, it is possible that other, non-
integrin, signaling pathways may also be involved. Indeed, it has
been proposed that a calcium-dependent mode of signaling is
utilized in Thy-1-mediated neurite outgrowth (Doherty et al.,
1993). Similarly, some anti-CD9 mAbs are thought to act via
calcium- and G-protein-mediated signaling (Seehafer and Shaw,
1991; Kroll et al., 1992). Although there is ample evidence that
CD9 interacts with the a3b1 integrin, Thy-1 has not been shown
to interact with integrins. However, the specificity of the a3b1
integrin perturbation is illustrated by lack of an effect on laminin,
consistent with a previous report (DeFreitas et al., 1995). In
addition, none of the control mAbs used shows any effect on
neurite outgrowth on any surface. These include anti-NCAM
monoclonal IgGs and F(ab) fragments; NCAM was chosen be-
cause it has been shown previously not to interact with CD9 in
neuronal cells (Schmidt et al., 1996). An anti-pg22 mAb also had
no effect, although it binds to these cells.
Thus, integrin a3b1 is involved with CD9-mediated neurite
outgrowth. It also mediates sympathetic neurite outgrowth on
thrombospondin (DeFreitas et al., 1995) and type I rat tail colla-
gen (this report), but not on collagen IV (DeFreitas et al., 1995)
or laminin (DeFreitas et al., 1995, this report).
Integrins a8b1 (Muller et al., 1995) and GPIIb-IIIa (Pelletier et
al., 1995) have also been implicated in cell spreading. In our
experiments, the cell spreading phenotype was not significantly
modified by the presence of the Ralph 3–1 mAb. Thus, the
interaction of B2C11 with CD9 leading to cytoskeletal rearrange-
ment and flattening could act by mimicking a putative CD9 ligand
that directly causes downstream signaling events, or it may involve
a different integrin. In addition, the B2C11-CD9 interaction may
induce a cis interaction with the a3b1 integrin, triggering an
integrin-associated signaling cascade leading to other cellular
changes. The possibility that CD9 signaling may involve interac-
tions with another set of cell surface receptors, the integrins,
suggests that CD9 may be part of a larger cell surface complex
that mediates interactions with the extracellular environment.
Such multicomponent complexes have been reported in various
cell lines (Berditchevski et al., 1996), including S-16 Schwann
(Hadjiargyrou et al., 1996) and N2A neuroblastoma cells
(Schmidt et al., 1996). In addition, the ability of CD9 to interact
with different integrins in distinct systems raises the possibility
that this may be a mechanism that underlies the specificity of CD9
functions.
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